{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:19:23Z","timestamp":1793330363169,"version":"4.5.0"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Intravenous thrombolysis (IVT) is an established therapy for acute ischemic stroke when administered within 4.5 hours of symptom onset. However, many patients present beyond this window or with unknown onset, and recent randomized clinical trials (RCTs) have evaluated whether imaging-selected patients may benefit from thrombolysis in the extended window.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate the functional and safety outcomes associated with IVT administered 4.5 hours or more after stroke onset.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n PubMed, Embase, and Cochrane Central Register of Controlled Trials were systematically searched from database inception through March 3, 2026.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n RCTs enrolling adults with acute ischemic stroke treated with IVT 4.5 hours or more after symptom onset were included. Trials comparing thrombolysis with placebo or standard medical care and reporting functional or safety outcomes were eligible.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Data were extracted independently by 2 reviewers following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Risk ratios (RRs) and mean differences with 95% CIs were pooled using random-effects models. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Primary outcomes were excellent functional outcome (modified Rankin scale scores of 0-1 at 90 days), good functional outcome (modified Rankin scale scores of 0-2 at 90 days), all-cause 90-day mortality, and symptomatic intracerebral hemorrhage (ICH).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Fourteen RCTs including 4174 patients (2102 in the thrombolysis group and 2072 in the control group) were analyzed, 9 of which were published within the past 5 years. IVT was associated with a higher likelihood of excellent functional outcome (RR, 1.22; 95% CI, 1.14-1.31) and good functional outcome (RR, 1.12; 95% CI, 1.06-1.18) at 90 days. Mortality did not differ between groups (RR, 1.13; 95% CI, 0.93-1.38), but thrombolysis was associated with an increased the risk of symptomatic ICH (RR, 2.44; 95% CI, 1.45-4.09). Absolute treatment effects corresponded to a number needed to treat of 12\u2009to 16 for an additional favorable outcome and a number needed to harm of 62 for symptomatic ICH.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this systematic review and meta-analysis of 14 RCTs, IVT administered beyond 4.5 hours after stroke onset was associated with improved functional outcomes despite an increased risk of symptomatic ICH, supporting extension of thrombolytic therapy beyond the conventional treatment window in appropriately imaging-selected patients.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.26990","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:30:33Z","timestamp":1786030233000},"page":"e2626990","source":"Crossref","is-referenced-by-count":3,"title":["Intravenous Thrombolysis Beyond the Conventional Time Window for Acute Ischemic Stroke"],"prefix":"10.1001","volume":"9","author":[{"given":"Shaan","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva A.","family":"Nischal","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy & Genetics, Medical Sciences Division, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kush M.","family":"Kale","sequence":"additional","affiliation":[{"name":"Department of Physiology, Anatomy & Genetics, Medical Sciences Division, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Gooch","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavropoula I.","family":"Tjoumakaris","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal M.","family":"Jabbour","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"10","key":"zoi260750r1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"23","author":"GBD 2021 Stroke Risk Factor Collaborators","year":"2024","journal-title":"Lancet Neurol"},{"issue":"12","key":"zoi260750r2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1474-4422(23)00277-6","article-title":"Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization-Lancet Neurology Commission.","volume":"22","author":"Feigin","year":"2023","journal-title":"Lancet Neurol"},{"issue":"3","key":"zoi260750r3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","article-title":"The impact of recanalization on ischemic stroke outcome: a meta-analysis.","volume":"38","author":"Rha","year":"2007","journal-title":"Stroke"},{"issue":"3","key":"zoi260750r4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMcp1917030","article-title":"Acute ischemic stroke.","volume":"383","author":"Powers","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"zoi260750r5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke.","volume":"333","author":"National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N Engl J Med"},{"issue":"13","key":"zoi260750r6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"zoi260750r7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2018.11122","article-title":"The acute stroke care revolution.","volume":"320","author":"Josephson","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"zoi260750r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.52927","article-title":"Trends in stroke thrombolysis care metrics and outcomes by race and ethnicity, 2003-2021.","volume":"7","author":"Man","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi260750r9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.125.053826","article-title":"Guidelines in action: extending the treatment window for thrombolysis in acute ischemic stroke.","author":"Stein","year":"2026","journal-title":"Stroke"},{"issue":"6","key":"zoi260750r10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/ijs.12011","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).","volume":"9","author":"Thomalla","year":"2014","journal-title":"Int J Stroke"},{"issue":"1","key":"zoi260750r11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ijs.12206","article-title":"A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).","volume":"9","author":"Campbell","year":"2014","journal-title":"Int J Stroke"},{"issue":"1","key":"zoi260750r12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/svn-2023-002310","article-title":"Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial.","volume":"9","author":"Xiong","year":"2024","journal-title":"Stroke Vasc Neurol"},{"key":"zoi260750r13","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000513","article-title":"2026 Guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association\/American Stroke Association.","author":"Prabhakaran","year":"2026","journal-title":"Stroke"},{"issue":"13","key":"zoi260750r14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jama.2026.0210","article-title":"Tenecteplase for acute non\u2013large vessel occlusion 4.5 to 24 hours after ischemic stroke.","volume":"335","author":"Ma","year":"2026","journal-title":"JAMA"},{"issue":"160","key":"zoi260750r16","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"zoi260750r17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7653","key":"zoi260750r18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"zoi260750r20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12975-024-01231-2","article-title":"Tenecteplase plus butylphthalide for stroke within 4.5\u20136 hours of onset (EXIT-BT): a phase 2 study.","volume":"16","author":"Chen","year":"2025","journal-title":"Transl Stroke Res"},{"issue":"19","key":"zoi260750r21","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke.","volume":"380","author":"Ma","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi260750r22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/ijs.12209","article-title":"Reperfusion after 4.5 hours reduces infarct growth and improves clinical outcomes.","volume":"9","author":"Pican\u00e7o","year":"2014","journal-title":"Int J Stroke"},{"issue":"5","key":"zoi260750r23","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/1747493019840938","article-title":"Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.","volume":"14","author":"Ringleb","year":"2019","journal-title":"Int J Stroke"},{"issue":"7","key":"zoi260750r24","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-guided thrombolysis for stroke with unknown time of onset.","volume":"379","author":"Thomalla","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi260750r25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5853\/jos.2023.00668","article-title":"Intravenous tenecteplase for acute ischemic stroke within 4.5\u201324 hours of onset (ROSE-TNK): a phase 2, randomized, multicenter study.","volume":"25","author":"Wang","year":"2023","journal-title":"J Stroke"},{"issue":"3","key":"zoi260750r26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa2402980","article-title":"Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy.","volume":"391","author":"Xiong","year":"2024","journal-title":"N Engl J Med"},{"issue":"5","key":"zoi260750r27","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1161\/STROKEAHA.119.028127","article-title":"Thrombolysis with alteplase at 0.6 mg\/kg for stroke with unknown time of onset.","volume":"51","author":"Koga","year":"2020","journal-title":"Stroke"},{"issue":"8","key":"zoi260750r28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJMoa2310392","article-title":"Tenecteplase for stroke at 4.5 to 24 hours with perfusion-imaging selection.","volume":"390","author":"Albers","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi260750r29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S1474-4422(22)00484-7","article-title":"Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.","volume":"22","author":"Roaldsen","year":"2023","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi260750r30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1161\/STROKEAHA.124.048375","article-title":"Tenecteplase thrombolysis for stroke up to 24 hours after onset with perfusion imaging selection: the CHABLIS-T II randomized clinical trial.","volume":"56","author":"Cheng","year":"2025","journal-title":"Stroke"},{"issue":"13","key":"zoi260750r31","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1056\/NEJMoa2413344","article-title":"Alteplase for posterior circulation ischemic stroke at 4.5 to 24 hours.","volume":"392","author":"Yan","year":"2025","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi260750r32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2025.12063","article-title":"Alteplase for acute ischemic stroke at 4.5 to 24 hours: the HOPE randomized clinical trial.","volume":"334","author":"Zhou","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"zoi260750r33","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1515\/jtim-2025-0048","article-title":"A multicenter, prospective, randomized, open-label, blinded endpoint trial of intravenous thrombolysis with tenecteplase for acute non-large vessel occlusion in extended time window (OPTION): rationale and design.","volume":"13","author":"Ma","year":"2025","journal-title":"J Transl Int Med"},{"issue":"9958","key":"zoi260750r34","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"zoi260750r35","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1161\/STROKEAHA.120.032837","article-title":"Time to thrombolysis and long-term outcomes in patients with acute ischemic stroke.","volume":"52","author":"Yafasova","year":"2021","journal-title":"Stroke"},{"issue":"9","key":"zoi260750r36","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1161\/STROKEAHA.118.021484","article-title":"Collateral clock is more important than time clock for tissue fate.","volume":"49","author":"Vagal","year":"2018","journal-title":"Stroke"},{"issue":"2","key":"zoi260750r37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jamaneurol.2020.4123","article-title":"Association of reperfusion after thrombolysis with clinical outcome across the 4.5- to 9-hours and wake-up stroke time window.","volume":"78","author":"Campbell","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"zoi260750r38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/17474930211006304","article-title":"Influence of time to endovascular stroke treatment on outcomes in the early versus extended window paradigms.","volume":"17","author":"Nogueira","year":"2022","journal-title":"Int J Stroke"},{"issue":"3","key":"zoi260750r39","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.0548","article-title":"Short-term safety and effectiveness for tenecteplase and alteplase in acute ischemic stroke.","volume":"8","author":"Rousseau","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi260750r40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031692","article-title":"Comprehensive review of tenecteplase for thrombolysis in acute ischemic stroke.","volume":"13","author":"Wang","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"zoi260750r41","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209903","article-title":"Tenecteplase vs alteplase in acute ischemic stroke within 4.5 hours.","volume":"103","author":"Palaiodimou","year":"2024","journal-title":"Neurology"},{"issue":"10459","key":"zoi260750r42","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/S0140-6736(24)01410-7","article-title":"Endovascular management of acute stroke.","volume":"404","author":"Nguyen","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"zoi260750r43","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2024.0589","article-title":"Time to treatment with intravenous thrombolysis before thrombectomy and functional outcomes in acute ischemic stroke.","volume":"331","author":"Kaesmacher","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"zoi260750r44","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214353","article-title":"Bridging or direct thrombectomy in posterior circulation large-vessel occlusion stroke.","volume":"105","author":"Chen","year":"2025","journal-title":"Neurology"},{"issue":"16","key":"zoi260750r45","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/CIRCULATIONAHA.122.063366","article-title":"Mechanical Thrombectomy Global Access For Stroke (MT-GLASS): A Mission Thrombectomy (MT-2020 Plus) Study.","volume":"147","author":"Asif","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"zoi260750r46","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1161\/STROKEAHA.119.028337","article-title":"Review of perfusion imaging in acute ischemic stroke: from time to tissue.","volume":"51","author":"Demeestere","year":"2020","journal-title":"Stroke"},{"issue":"10262","key":"zoi260750r47","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/S0140-6736(20)32163-2","article-title":"Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data.","volume":"396","author":"Thomalla","year":"2020","journal-title":"Lancet"},{"key":"zoi260750r15","unstructured":"Higgins? JPT, Thomas? J, Chandler? J, Cumpston? M, Li? T, Page? MJ. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5 (updated August 2024). Cochrane; 2024. Accessed June 18, 2026. http:\/\/www.cochrane.org\/handbook"},{"key":"zoi260750r19","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing [computer program]. Version 4.4.2. R Foundation for Statistical Computing; 2023. Accessed June 18, 2026. https:\/\/R-project.org"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852517\/patel_2026_oi_260750_1790100516.7217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:00:20Z","timestamp":1790607620000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852517"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.26990","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]}}}